The perspectives for porcine-to-human xenografts.
The shortage of donated human organs for transplantation continues to be a life threatening problem for patients suffering from complete organ failure. Although this gap is increasing due to the demographic changes in aging Western populations, it is generally accepted that international trading in human organ is not an ethical solution. Alternatives to the use of human organs for transplantation must be developed and these alternatives include stem cell therapy, artificial organs and organs from other species, i.e. xenografts. For practical reasons but most importantly because of its physiological similarity with humans, the pig is generally accepted as the species of choice for xenotransplantation. Nevertheless, before porcine organs can be used in human xenotransplantation, it is necessary to make a series of precise genetic modifications to the porcine genome, including the addition of genes for factors which suppress the rejection of transplanted porcine tissues and the inactivation or removal of undesirable genes which can only be accomplished at this time by targeted recombination and somatic nuclear transfer. This review will give an insight into the advances in transgenic manipulation and cloning in pigs--in the context of porcine-to-human xenotransplantation.
Petersen
Bjoern
B
Institute of Farm Animal Genetics (FLI), Department of Biotechnology, Hoeltystrasse 10, 31535 Neustadt, Germany.
Carnwath
Joseph W
JW
Niemann
Heiner
H
D000818:Animals; D030801:Animals, Genetically Modified / Q000235:genetics* / Q000276:immunology; D019976:Cloning, Organism; D020077:Endogenous Retroviruses / Q000235:genetics* / Q000276:immunology; D005818:Genetic Engineering; D006084:Graft Rejection / Q000235:genetics / Q000276:immunology; D006085:Graft Survival / Q000235:genetics / Q000276:immunology; D006801:Humans; D053652:Nuclear Transfer Techniques; D013552:Swine; D014183:Transplantation, Heterologous / Q000639:trends*